Results 131 to 140 of about 18,054 (201)

Heme-deficient metabolism and impaired cellular differentiation as an evolutionary trade-off for human infectivity in Trypanosoma brucei gambiense

open access: green, 2022
Eva Horáková   +8 more
openalex   +1 more source

Differences in pathogenicity and virulence of Trypanosoma brucei gambiense field isolates in experimentally infected Balb/C mice [PDF]

open access: green, 2018
Jacques Kaboré   +13 more
openalex   +1 more source

Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial

open access: yesThe Lancet, 2018
V. K. B. K. Mesu   +25 more
semanticscholar   +1 more source

The detection and treatment of human African trypanosomiasis

open access: yesResearch and Reports in Tropical Medicine, 2012
Bernard Bouteille,1 Alain Buguet21Laboratory of Parasitology, Dupuytren University Hospital of Limoges, France; 2Polyclinic Marie-Louise Poto-Djembo, Pointe-Noire, CongoAbstract: Human African trypanosomiasis (HAT) is caused by the injection of ...
Bouteille B, Buguet A
doaj  

NECT Is Next: Implementing the New Drug Combination Therapy for Trypanosoma brucei gambiense Sleeping Sickness

open access: gold, 2010
Oliver Yun   +4 more
openalex   +2 more sources

Alterations in thyroid function in patients with Trypanosoma brucei gambiense infection

open access: yesTransactions of the Royal Society of Tropical Medicine and Hygiene, 1989
Boersma, A.   +6 more
openaire   +4 more sources

Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor

open access: green, 2010
Rudo Kieft   +5 more
openalex   +1 more source

Human Macrophage Tumor Necrosis Factor (TNF)–α Production Induced byTrypanosoma brucei gambienseand the Role of TNF‐α in Parasite Control [PDF]

open access: bronze, 2001
Sylvie Daulouède   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy